This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Eiji Fukui: Innovator in Pharmaceutical Preparations
Introduction
Eiji Fukui is a notable inventor based in Kakogawa, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the controlled release of medicinal active ingredients. With a total of 2 patents, his work has the potential to enhance the effectiveness of oral medications.
Latest Patents
Fukui's latest patents focus on a pharmaceutical preparation designed for oral administration. This innovative preparation is controlled to release a medicinal active ingredient at a targeted site in the intestinal tract. The formulation consists of a core containing the medicinal active ingredient, surrounded by a press-coated layer made of an enteric polymer. This design ensures that the active ingredient is not released during its time in the stomach. Instead, it is discharged only after reaching the targeted site in the intestine, allowing for efficient delivery of the medicinal component.
Career Highlights
Eiji Fukui is associated with Tanabe Seiyaku Company, Limited, where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to advancements in drug delivery systems, which are crucial for improving patient outcomes.
Collaborations
Fukui has collaborated with notable colleagues, including Tami Hanamori and Hiroyuki Yoshino. These partnerships have likely fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Eiji Fukui's contributions to the field of pharmaceutical preparations demonstrate his commitment to innovation and improving healthcare. His patents reflect a deep understanding of drug delivery mechanisms, which can significantly impact patient treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile